Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis severity and patients' age: An exploratory sub‐analysis of the ABPARO trial

AIM: The aim was to identify benefit thresholds for clinical variables. We hypothesize, if variables fall below or exceed these threshold levels, systemic amoxicillin/metronidazole may contribute to reducing progression of periodontitis. MATERIAL & METHODS: This is an explorative per‐protocol co...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Clin Periodontol
मुख्य लेखकों: Eickholz, Peter, Koch, Raphael, Kocher, Thomas, Hoffmann, Thomas, Kim, Ti‐Sun, Meyle, Joerg, Kaner, Doğan, Schlagenhauf, Ulrich, Harmsen, Dag, Harks, Inga, Ehmke, Benjamin
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2019
विषय:
Periodontal Therapy
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594242/
https://ncbi.nlm.nih.gov/pubmed/30825384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpe.13096
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन